Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RCOR | Option | Award | $0 | +239K | $0.00 | 239K | Sep 3, 2021 | Common Stock | 239K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | In connection with Dr. Cook's employment as the Chief Executive Officer of the Issuer, she received a true-up equity grant. |
F2 | The stock option will vest and become exercisable in full on September 3, 2025, with 25% vesting on September 3, 2022, and the remainder vesting in equal monthly installments on the 3rd of each month for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting date. |